Document is current
Any future updates will be listed below
-
Authors
Osumili, Beatrice
Sapin, Hélène
Yang, Zhengyu
Ranta, Kari
Paik, Jim S.
Blüher, Matthias
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 12 March 2025
First Online: 11 April 2025
Declarations
:
: Beatrice Osumili, Kari Ranta, Hélène Sapin, and Jim S. Paik are employees and minor shareholders of Eli Lilly and Company. Zhengyu Yang was an employee and shareholder of Eli Lilly and Company during the development of the NMA and the manuscript and is currently an employee of Amylyx Pharmaceuticals. Matthias Blüher received honoraria as a consultant and speaker for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly and Company, Novartis, Novo Nordisk, Pfizer, and Sanofi.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
